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Maternally Inherited Birk Barel Mental Retardation
Dysmorphism Syndrome Caused by a Mutation in the
Genomically Imprinted Potassium Channel KCNK9
Ortal Barel,1,6 Stavit A. Shalev,2,6 Rivka Oﬁr,1 Asi Cohen,3 Joel Zlotogora,4 Zamir Shorer,5
Galia Mazor,2 Gal Finer,1 Shareef Khateeb,1 Noam Zilberberg,3 and Ohad S. Birk1,5,*
We describe a maternally transmitted genomic-imprinting syndrome of mental retardation, hypotonia, and unique dysmorphism with
elongated face. We mapped the disease-associated locus to ~7.27 Mb on chromosome 8q24 and demonstrated that the disease is caused
by a missense mutation in the maternal copy of KCNK9 within this locus. KCNK9 is maternally transmitted (imprinted with paternal
silencing) and encodes K2P9.1, a member of the two pore-domain potassium channel (K2P) subfamily. The mutation fully abolishes
the channel’s currents—both when functioning as a homodimer or as a heterodimer with K2P3.1.Introduction
In contrast with Mendel’s theory, for some autosomal
human genes, only the paternal or the maternal copy of
the gene is expressed. Thus, for a gene that is normally im-
printedwith paternal silencing, amutation in thematernal
copyof thegenewill result indisease,whereas amutation in
the paternal copy will have no effect. Thus far, more than
80 genes have been demonstrated to be imprinted in hu-
mans and mice, yet only a few have been associated with a
human disease.1 To date, several recognizable developmen-
tal syndromes due to abnormalitieswithin speciﬁcdomains
havebeendescribed. Themost studiedgenomic-imprinting
defects in humans are Prader-Willi (PWS [MIM 176270])
and Angelman (AS [MIM 105830]) syndromes, which are
due to paternal and maternal imprinting disorders of genes
on chromosome 15q11-q13, and Beckwith-Wiedemann
(BWS [MIM 130650]) and Russell-Silver (SRS [MIM
180860]) syndromes,whichare associatedwithgenomic im-
printing of genes in two adjacent domains on chromosome
11p15.5. Other human imprinting disorders include tran-
sient neonatal diabetes (at 6q24) (MIM 601410), maternal
and paternal chromosome 14 uniparental-disomy syn-
dromes (at 14q32), and pseudohypoparathyroidism type 1b
(PHP1B [MIM 603233]) (at 20q13.2).1 We now describe
a human syndrome of mental retardation, hypotonia, and
characteristic dysmorphism caused by a mutation in a
genomically imprinted gene on chromosome 8.
Material and Methods
The study was approved by the Institutional Review Board of
Soroka Medical Center.The AmeGenome-wide linkage analysis with the 400 microsatellite
markers (ABI PRISM Linkage Mapping Set MD10, Applied Biosys-
tems) and ﬁne mapping were done as previously described.2 Statis-
tical analysis was donewith an autosomal-dominant diseasemodel
assuming imprinting with paternal silencing. Extended two-point
LODscoreswerecalculatedontheentirekindredwithSUPERLINK.3
Fine mapping of the disease-associated genomic locus was per-
formed with 18 markers designed with Tandem Repeats Finder.4
Coding sequences of potassium channel, subfamily K, member 9
(KCNK9 [MIM 605874]) were PCR ampliﬁed from genomic DNA
and sequenced. Analysis of the mutation in the entire family
and controls was performed by restriction analysis of KCNK9
exon 2 with the restriction enzyme NlaIV on PCR products (the
770G/A mutation abolishes a recognition site). PCR primers
used are available upon request.
Electrophysiology
Full-length cDNAs of human KCNK9 (TASK3; K2P9.1; NT_008046;
NP_057685.1) and human KCNK3 (TASK1; K2P3.1; NP_002237;
MIM 603220) channels were cloned into pMAX and pRAT plas-
mids, respectively; both plasmids include a T7 RNA polymerase
promoter to enable cRNA synthesis, as well as 30-UTR and 50-
UTR sequences of the Xenopus laevis b-actin gene to ensure efﬁ-
cient expression in Xenopus oocytes. The mutant was generated
with theQuickchange site-directedmutagenesis technique (Strata-
gene, La Jolla, CA). The mutation was conﬁrmed by DNA sequenc-
ing. cRNA was transcribed in vitro with T7 polymerase and the
AmpliCap High YieldMessageMaker (Epicenter, Madison,WI) kit.
Xenopus laevis oocytes were isolated and injected 7 ng of cRNA
in 20 nl of RNase-free water. Whole-cell currents were measured
3–4 days after injection by the two-electrode voltage-clamp tech-
nique (GeneClamp 500B, Axon Instruments, Union City, CA).
Data were sampled at 2 kHz and ﬁltered at 0.5 kHz with Clampex
9.0 software (Axon Instruments, Union City, CA). The pipettes
contained 3 M KCl, and the bath solution contained 4 mM KCl,
96 mM NaCl, 1 mM MgCl2, 0.3 mM CaCl2, and 5 mM HEPES
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Results
Clinical Phenotype of the Syndrome
An Israeli Arab kindred presented with an apparently ma-
ternally transmitted (imprinted with paternal silencing)
syndrome (Figure 1A). All affected individuals had moder-
ate to severe mental retardation and were hyperactive. Se-
vere feeding difﬁculties at infancy (requiring tube feeding
in most) were followed in all patients by dysphagia of solid
foods until near puberty. Generalized hypotonia at an early
age was followed by weakness of proximal muscles and of
the supra- and infrascapular and trapeziusmuscles later on.
Coordination, tendon reﬂexes, deep and superﬁcial sensa-
tion, and vibration were all within normal limits. Babinski
sign was negative. Hearing, vision, and ophthalmologic
examination were normal. As depicted in Figures 1B–1D,
similar dysmorphic features were found in affected indi-
viduals, with most elements being more prominent at
younger ages: The face was elongated with narrow bitem-
poral diameter, mild atrophy of temporalis and masseter
muscles, and reduced facial movements. The eyebrows
were ﬂared, bushy, and arched upward, with downturned
eyelids and sparse eyelashes in the inner third of the lower
eyelids, and with congested conjunctivae in most patients.
Ears were mildly protruding with a very prominent fold of
the crux of the helix and a prominent antihelical fold. The
nasal bridge was high and narrow with a broad nasal tip.
The colummella was normal, but the philtrum was ex-
tremely short, broad, and thick in all patients. The maxil-
lary and premaxillary regions were prominent, with hypo-
tonia of the mandible and micrognathia—leading (in
combination with the short philtrum) to an open mouth.
The lips were thick, with downturned upper lips (‘‘ﬁsh
mouth’’) and a lower lip that was shorter than the upper
lip. Most patients had a narrow, high-arched palate with
full or submucous cleft and dysphonic speech. Large and
protruding incisors were seen in younger patients
(Figure 1D). All patients had narrow, elongated necks,
trunks, and feet. In some infants, mild joint contractures
of the hips, elbows, phalanx, and feet were present and be-
came prominent with age. A pilonidal dimple or sinus was
evident in most patients. Extensive skeletal X-ray studies
were normal. Thorough metabolic work-up, karyotypes,
blood levels of muscle-associated enzymes, and EEG and
brain CT studies were normal (mild periventricular leuko-
malacia was present in a single child). Muscle biopsies in
two patients were compatible with spinal muscular atro-
phy (SMA [MIM 253300]), with normal molecular SMA
tests. Mitochondria appeared normal on EM examination,
and normal activity of themitochondrial respiratory-chain
enzymes was demonstrated in muscle.
Linkage-Analysis Studies
Genome-wide linkage analysis of seven affected individ-
uals, one healthy individual, and four obligatory-transmit-
ting mothers was done with 400 ﬂuorescent end-labeled194 The American Journal of Human Genetics 83, 193–199, Augustpolymorphic markers as previously described.4 Assuming
the disease is caused by a mutation in a paternally im-
printed gene, we looked for a genomic locus with a haplo-
type shared by the (obligatory transmitting) healthy
mothers and their affected children, but not their healthy
children. Studies using polymorphic markers excluded
Figure 1. Clinical Features
(A) Pedigree of the affected Israeli Arab family. The numbers
denote individuals whose DNA samples were analyzed. It can be
seen that the disease is maternally transmitted (paternally im-
printed).
(B and C) Dysmorphic features of affected siblings.
(D) Prominent incisor teeth of young affected individual.8, 2008
noninformative regions as well as six of seven genomic loci
identiﬁed (data not shown). The remaining single locus
spanned ~37.91 cM (corresponding to 26.34 Mb) on chro-
mosome 8q24, between marker D8S514 and the telomeric
end of 8q. Fine mapping of the locus was done, testing
DNA samples of the 27 available family members (11 af-
fected and 16 nonaffected) with additional polymorphic
markers in the identiﬁed interval (details in Material and
Methods). One affected child (26) in the family presented
with a crossing-over event at ATCT-1389, setting the cen-
tromeric border of the common interval at ATCT-1389, de-
lineating a ~7.27 Mb locus (harboring ~153 known or pre-
dicted genes) common to all affected individuals and their
mothers in the family (Figure 2A). Two-point analysis with
SUPERLINK3 demonstrated a LOD score above 5 at q¼ 0 for
two separate markers within the haplotype (Figure 2B).
Determination of the Speciﬁc Gene Mutation
The next step was to identify and sequence candidate
genes within the locus that are known to be imprinted in
humans or mice. Using speciﬁc DNA sequences character-
istic of known imprinted genes to screen for previously un-
reported potentially imprinted genes, Luedi et al. recently
identiﬁed two human imprinted genes on chromosome 8,5
one of which lies within our identiﬁed locus: KCNK9 (also
known as K2P9.1 and TASK-3). KCNK9 has been shown to
be imprinted with paternal silencing in humans and
mice and to be exclusively expressed from the maternal al-
lele in the brain.6 As shown in Figure 3, sequence analysis
of KCNK9 (GenBank accession number NM_016601) in af-
fected individuals revealed a 770G/Amutation in exon 2,
replacing glycine at position 236 by arginine (G236R). The
mutation abolishes a recognition site of the restriction en-
zyme NlaIV, allowing easy analysis of the entire family and
controls. Analysis of all 27 DNA samples of the kindred was
compatible with the mutation being associated with the
disease phenotype, implying dominant inheritance with
paternal imprinting. The mutation was not found in any
of 548 chromosomes from ethnically matched controls.
Determination of the Physiological Effect
of the K2P9.1 Mutation
The biophysical implications of the K2P9.1-G236R muta-
tion were studied with the two-electrode voltage-clamp
technique (Figure 4). On the basis of the published struc-
ture of the KcsA potassium channel,7 the small G236 resi-
due (homologous to KcsA-G104) is expected to lie within
the ion-conduction pathway of the channel (Figure 4E).
Hence, the introduction of the positively charged arginine
residue at this position is expected to interfere with
potassium conductance by forming both physical and
electrostatic barriers. Wild-type and mutant channel
cRNAs were transcribed in vitro and injected to Xenopus
laevis oocytes, and whole-cell currents were measured 3–4
days subsequent to injection. Unlike wild-type channels,
K2P9.1-G236R channels produced no measurable currents
(Figure 4). Moreover, coexpression of mutant and wild-The Ametype channels resulted in a ~4-fold decrease in wild-type
currents (Figures 4B and 4C). Furthermore, a similar dom-
inant-negative effect was observed when the K2P9.1-
G236R mutant was coexpressed with human K2P3.1 (also
known as TASK-1, KCNK3) (Figure 4C), a closely related
K2P channel, known to form heterodimers with K2P9.1 in
expression systems as well as in native tissues.8 Thus, the
loss of current seen in the heterologous system is likely
to occur also in vivo and cause the disease. The loss of
current could be either due to expression of nonfunctional
channels or due to failure to trafﬁc to the membrane.
Discussion
Genomic imprinting has been associated with very few
human phenotypes, caused by defects in speciﬁc imprint-
ing domains on human autosomes. Each domain is under
the regulatory control of an ‘‘imprinting center’’ that
harbors a differentially methylated region. A number of
molecular mechanisms result in differential silencing of
some genes within these domains, making them
vulnerable to naturally occurring genetic and epigenetic
aberrations.1
We clearly demonstrate that the disease is caused by
a mutation in the maternal copy of KCNK9 and that the
mutation fully abolishes the activity of this potassium
channel both when acting as a homodimer and when
functioning as a heterodimer. KCNK9 was recently shown
to be imprinted with paternal silencing, well in line with
the form of heredity demonstrated in the kindred pre-
sented here. KCNK9 encodes K2P9.1 potassium channel,
a member of the two-pore domain (K2P) family.
9 K2P
potassium channels comprise the newest branch of the
potassium-channel superfamily serving to carry leak or
‘‘background’’ currents that are mostly time- and voltage-
independent. K2P channels operate as dimers with four
transmembrane segments and two pore-forming domains
in each subunit (Figure 4D). Leak currents shape the dura-
tion, frequency, and amplitude of action potentials and
regulate cell responsiveness and excitability8 by modulat-
ing membrane resting potential and resistance. The 15 hu-
man members of the K2P channel family have a wide and
diverse anatomical distribution pattern and are involved
in numerous physiological processes. To our knowledge,
this is the ﬁrst report of a disease-causing mutation in
amember of this gene family. Mammalian K2P9.1 channels
are involved in various physiological functions, including
adjustment of neuronal excitability10–13 and regulation of
aldosterone secretion.14 Human K2P9.1 channels are
expressed primarily in the central nervous system and par-
ticularly in the cerebellum.15 K2P9.1 activity is modulated
by extracellular pH, neurotransmitters, volatile anesthetics,
and more.9
KCNK9 resides within 6.2 Mb of the marker D8S256,
linked with bipolar disorder,16 and has been suggested to
be a candidate for idiopathic-absence epilepsies.17 K2P9.1rican Journal of Human Genetics 83, 193–199, August 8, 2008 195
Figure 2. Mapping the KCNK9 Locus
(A) Partial pedigree and segregation analysis of the affected family. The numbers denote individuals whose DNA samples were analyzed.
Haplotypes are represented as columns of numbers; the disease-associated haplotype is shaded. Physical distances between the markers
are shown.
(B) Two-point LOD-score analysis for the polymorphic markers at the KCNK9 locus. The arrow indicates the gene location.channels were suggested to play an important role in
Kþ-dependent apoptosis of cerebellar granule neurons in
culture18 and in maturation of neurons in the cerebellum
during neuronal development.19 Indeed, through the use
of knockout mice, K2P9.1 was shown to modulate action-
potential ﬁring in cerebellar granule neurons,20 circadian196 The American Journal of Human Genetics 83, 193–199, Augustrhythms, cognitive functions, and speciﬁc pharmacologi-
cal effects.20,21 Moreover, we expect that the physiological
impact of a dominant loss-of-function mutation might
exceed that of a complete null mutation, because non-
functional K2P9.1 protein might affect the function
of associated proteins such as K2P3.1 (Figure 4C) and8, 2008
Figure 3. Analysis of the 770G/A Mutation in Exon 2 of KCNK9
Sequence analysis of a healthy obligatory-carrier mother and her affected and healthy offspring.hyperpolarization-activatedcyclic-nucleotide-gated (HCN2)
channels.22 In cerebellar granule neurons, the standing
outward Kþ current (IKso) corresponds to either K2P9.1
homomericorK2P9.1/K2P3.1heteromeric channels.Because
K2P3.1 knockout mice exhibited compromised motor per-
formance consistent with altered cerebellar function,10
a mutated K2P9.1 channel is expected to further diminish
IKso and perturb neuronal activity. In addition, membrane
resting potential of thalamocortical relay neurons is
shaped by the interaction of K2P9.1 and HCN2 channels.
22
HCN channels that conduct Ih, a hyperpolarization-
triggered cationic current that contributes to the mainte-
nance of neuronal membrane potential, were recently
proposed to take part in febrile seizures and epilepsy.23 We
thus hypothesize that damaging the possible K2P9.1-
HCN2 association might also alter the Ih current and
potentially contribute to the phenotype described here.
Moreover, we expect K2P9.1 to have a more pivotal role
in human cerebellum than in mice because of its high rel-
ative expression levels.15 Taken together, the K2P9.1 loss
of function during brain development speciﬁcally disrupts
the efﬁciency of the cerebro-cerebellar pathways, resulting
in cognitive deﬁcits and deterioration in muscle strength
and function.
Imprinting of both the human and mouse orthologs of
this gene does not seem to be regulated by short-range
cis-acting differential methylation at their CpG-island
promoter.6 In the mouse, Kcnk9 is located on chromosome
15, 260 kb downstream of the imprinted Peg13 gene,
a non-protein-coding RNA gene of unknown function.
Similar to Kcnk9, Peg13 is expressed predominantly in
brain, but, in contrast, the maternal allele is silenced and
marked by DNA methylation in somatic tissues.24 Nearly
full methylation of the Peg13 differentially methylated re-
gion (DMR) was shown in mature oocytes with near com-
plete absence of methylation in sperm DNA. It was thus
hypothesized that the nearby murine Peg13-DMR acts as
a long-range acting imprinting control element control-
ling the imprinting of the distal murine Kcnk9 gene. To
date, there is no known Peg13 or Peg13-DMR human ho-
molog,6,24,25 and the mechanism of imprinting of human
KCNK9 remains to be elucidated.The AmeTo our knowledge, the syndrome we describe is the ﬁrst
human syndrome caused by a defect in a speciﬁc im-
printed gene on chromosome 8. Imprinting syndromes
can evolve from a mutation or deletion of the ‘‘active’’
copy of an imprinted gene, but they can also be caused
by defects in an adjacent imprinting center or by uniparen-
tal disomy of the ‘‘inactive’’ copy of the gene. A single pre-
vious report suggested possible association of maternal
uniprental disomy of chromosome 8 with early-onset ileal
carcinoid tumor.26 This ﬁnding does not conﬂict with our
data, and it remains to be seen whether this single case is
an incidental ﬁnding or whether it reﬂects a true pheno-
typic effect of unimaternal disomy of chromosome 8. Of
more relevance to our ﬁndings is a single case report27
demonstrating that paternal uniparental disomy of chro-
mosome 8 found in lymphocytes is not associated with
a human clinical phenotype. This latter report in conjunc-
tion with our data can be explained in several ways. One
option is that the previously reported case of unipaternal
disomy of chromosome 8 was a mosaic. Thus, for instance,
it might reﬂect a trisomy rescue that occurred differently in
various tissues, resulting in unipaternal disomy in blood
cells, yet in one maternal and one parental copy of chro-
mosome 8 in all or most cells of neuronal tissues. However,
because there is no evidence of anymoasicism in the blood
of the individual reported, the above suggestion is possible
yet not very likely. Alternatively and perhaps more likely,
the previously reported case of paternal uniparental dis-
omy is indeed such in all tissues. In such a case, it might
well be that complete null mutation and loss of function
of human K2P9.1 is compensated for by other molecules
and has no phenotypic effect. This would then suggest
that themissensemutation we describemight exert a dom-
inant-negative effect on other molecules, as suggested by
the dominant-negative effect that was observed when
the K2P9.1-G236R mutant was coexpressed with human
K2P3.1 (Figure 4C). If this is the case, this would be to the
best of our knowledge the ﬁrst report of a mutation in a ge-
nomically imprinted gene causing a human phenotype
through a dominant-negative effect on other (nonim-
printed) molecules. If this interpretation is true, null muta-
tions (or deletions) of KCNK9 would have no phenotypicrican Journal of Human Genetics 83, 193–199, August 8, 2008 197
Figure 4. The K2P9.1-G236R Mutant Does Not Produce Functional Channels
Macroscopic currents measured by two-electrode voltage clamp.
(A) Raw current traces for representative oocytes expressing WT-K2P9.1 and K2P9.1-G236R channels and bathed in 5 mM potassium
solution. Oocyte membrane potential was held at 80 mV and pulsed from 155 to þ40 mV in 15 mV voltage steps for 70 ms with
1 s interpulse intervals.
(B) K2P9.1 steady-state current-voltage relationships for WT-K2P9.1 (full circles), K2P9.1-G236R mutated channels (open circles), and
coexpression of WT-K2P9.1 þ K2P9.1-G236R (triangles) (mean5 SEM, n ¼ 6-9 cells).
(C) Currents at þ40 mV of oocytes injected with equal cRNA amounts of the different channels, as indicated (mean5 standard error of
the mean, n ¼ 6–9 cells).
(D) Predicted membrane topology of a K2P9.1 subunit indicating the two P domains and four transmembrane segments (M1–4). The
predicted position of G236 is highlighted in red.
(E) Surface representation of two opposing KcsA subunits.7 G104 was replaced by an arginine residue (highlighted in red), as in the
K2P9.1-G236 mutant. Ribbon representation of the carbon backbone is in dark green, and potassium ions are in light green. Molecular
graphics images were produced with the UCSF Chimera (an extensible molecular-modeling system) package from the Resource for Bio-
computing, Visualization, and Informatics at the University of California, San Francisco.effect in humans. Future identiﬁcation and characteriza-
tion of more cases of human unipaternal disomy of chro-
mosome 8 will allow better understanding of the mecha-
nism through which the phenotype we describe evolves
and will determine whether unipaternal disomy of human
chromsome 8 (or null mutations or deletions of KCNK9)
are of clinical signiﬁcance.
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